Dr. Bryant received her MD degree from the Medical College of Wisconsin and completed her five-year residency in Radiation Oncology at Emory University School of Medicine in Atlanta, Georgia. She is Board Certified in Radiation Oncology and accepted a faculty position at Emory following completion of her residency. She is trained and knowledgeable in the use of the state-of-the-art radiation therapy Linac, utilizing the Varian Trilogy and TrueBeam. The Trilogy and True Beam deliver precise radiation therapy treatment, maximally avoiding normal tissues, to improve the opportunity for patients to receive the most effective and safest therapy. Dr. Bryant is also proficient in radioactive prostate seed implantation. She is a member of the American Medical Association, the Florida Medical Association, the American Society of Therapeutic Radiology and Oncology, the American College of Radiology and the American Brachytherapy Society.
Anil Dhople, MD is Board-certified by the American Board of Radiology in Radiation Oncology. He is an expert in the utilization and delivery of state-of-the-art radiation options such as stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), and stereotactic radiosurgery (SRS).
Dr. Dhople earned his medical degree from the University of Florida College of Medicine. He completed a residency in Radiation Oncology at the University of Maryland School of Medicine in Baltimore, Maryland. During his residency, he completed specialty training rotations at prestigious cancer centers including Memorial Sloan Kettering Cancer Center in New York City; Princess Margaret Hospital in Toronto, Canada; William Beaumont Hospital in Detroit, Michigan; Washington University in St. Louis, Missouri, and St. Jude Children's Research Hospital in Memphis, Tennessee.
Nanialei Golden, MD is Board-certified by the American Board of Radiology in Radiation Oncology. She is active on many cancer-related committees including the Brevard County American Cancer Society Board of Directors. She has extensive experience in image guided radiation therapy (IGRT), intensity modulated radiation therapy (IMRT), brachytherapy (including prostate and gynecologic malignancies), stereotactic body radiotherapy (SBRT), and stereotactic radiosurgery (SRS), and lectures internationally on the innovative cancer therapeutics.
Dr. Golden earned her medical degree from the Chicago Medical School in Chicago, Illinois. She completed her internship at Alameda County Medical Center and her residency at Northwestern University in Chicago, Illinois. Subsequently, she achieved fellowship training in Gamma Knife Radiosurgery at the University of California in San Francisco. In 2010 Dr. Golden received her Fellowship through the American College of Radiation Oncology for 10+ years of meritorious service in the field of Radiation Oncology.
Dr. Prendergast is a Phi Beta Kappa graduate from the University of Notre Dame in 2004. He graduated from The University of Florida College of Medicine in 2008 where he was selected for The Alpha Omega Alpha Medical Honor Society. He completed his internship at Presbyterian- St. Luke’s Medical Center in Denver Colorado in 2009, followed by a Clinical and Translational Science Program at The University of Alabama, at Birmingham (UAB) in 2011. Dr. Prendergast completed his residency in Radiation Oncology at UAB in July 2013. Dr. Prendergast is a board certified diplomate of The American Board of Radiology.
Currently, Dr. Prendergast is a member of the Radiologic Society in North America (RSNA); American Society of Therapeutic Radiation Oncology (ASTRO); and the American College of Radiation Oncology (ACRO), where he has been appointed to the Resident Committee from 2011- 2013.